Skip to main content

Karl Paul Link

Mark A. Stahmann (left) and Karl Paul Link discovered dicumarol, a powerful anticoagulant. They are shown in 1940 in a UW-Madison biochemistry laboratory. Courtesy of The University of Wisconsin Collection
Society: ACSMain Category: ChemicalSub Category: MedicalEra: 1950-1959DateCreated: 1954420 Henry MallMadisonState: WIZip: 53706Country: USAWebsite: https://www.acs.org/education/whatischemistry/landmarks/warfarin.htmlCreator: Karl Paul Link

University of Wisconsin-Madison biochemist Karl Paul Link and his lab isolated an anticoagulant compound from spoiled sweet clover hay in 1939, after a Wisconsin farmer's cattle began hemorrhaging from the moldy feed. Their research led to warfarin, marketed first as a rat poison in 1948 and later approved as the blood-thinning drug warfarin sodium (Coumadin) in 1954. It remains one of the world's most widely prescribed anticoagulants.

YearAdded:
2022
Image Credit: The University of Wisconsin Collection, The American Chemical SocietyImage Caption: Mark A. Stahmann (left) and Karl Paul Link discovered dicumarol, a powerful anticoagulant. They are shown in 1940 in a UW-Madison biochemistry laboratory.
Courtesy of The University of Wisconsin Collection
Subscribe to Karl Paul Link

Innovations

Mark A. Stahmann (left) and Karl Paul Link discovered dicumarol, a powerful anticoagulant. They are shown in 1940 in a UW-Madison biochemistry laboratory. Courtesy of The University of Wisconsin Collection

University of Wisconsin-Madison biochemist Karl Paul Link and his lab isolated an anticoagulant compound from spoiled sweet clover hay in 1939, after a Wisconsin farmer's cattle began hemorrhaging from the moldy feed. Their research led to warfarin, marketed first as a rat poison in 1948 and…

Read More

We hope you enjoyed this essay.

Please support America's only magazine of the history of engineering and innovation, and the volunteers that sustain it with a donation to Invention & Technology.

Donate

Stay informed - subscribe to our newsletter.
The subscriber's email address.